Advertisement

Topics

Innovation Pharma (Formerly known as Cellceutix) Completes Patient Enrollment In Phase II Study Of Brilacidin For The Prevention Of Severe Oral Mucositis

20:00 EDT 6 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Innovation Pharma (Formerly known as Cellceutix) Completes Patient Enrollment In Phase II Study Of Brilacidin For The Prevention Of Severe Oral Mucositis

NEXT ARTICLE

More From BioPortfolio on "Innovation Pharma (Formerly known as Cellceutix) Completes Patient Enrollment In Phase II Study Of Brilacidin For The Prevention Of Severe Oral Mucositis"

Quick Search
Advertisement